These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversing a model of Parkinson's disease with in situ converted nigral neurons. Qian H; Kang X; Hu J; Zhang D; Liang Z; Meng F; Zhang X; Xue Y; Maimon R; Dowdy SF; Devaraj NK; Zhou Z; Mobley WC; Cleveland DW; Fu XD Nature; 2020 Jun; 582(7813):550-556. PubMed ID: 32581380 [TBL] [Abstract][Full Text] [Related]
4. Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis. Farzanehfar P Neurochem Res; 2016 Dec; 41(12):3161-3170. PubMed ID: 27613619 [TBL] [Abstract][Full Text] [Related]
5. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis. Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068 [TBL] [Abstract][Full Text] [Related]
8. Harnessing neurogenesis for the possible treatment of Parkinson's disease. Lamm O; Ganz J; Melamed E; Offen D J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264 [TBL] [Abstract][Full Text] [Related]
9. Cell transplantation in the damaged adult brain. Jaber M; Benoit-Marand M; Prestoz L; Gaillard A Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517 [TBL] [Abstract][Full Text] [Related]
10. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases. Pan-Montojo F; Funk RH CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153 [TBL] [Abstract][Full Text] [Related]
11. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250 [TBL] [Abstract][Full Text] [Related]
12. Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior. Van Kampen JM; Eckman CB J Neurosci; 2006 Jul; 26(27):7272-80. PubMed ID: 16822985 [TBL] [Abstract][Full Text] [Related]
14. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079 [TBL] [Abstract][Full Text] [Related]
15. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Aponso PM; Faull RL; Connor B Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835 [TBL] [Abstract][Full Text] [Related]
17. Resident adult neural stem cells in Parkinson's disease--the brain's own repair system? van den Berge SA; van Strien ME; Hol EM Eur J Pharmacol; 2013 Nov; 719(1-3):117-127. PubMed ID: 23872414 [TBL] [Abstract][Full Text] [Related]
18. Adult neural stem/progenitor cells in neurodegenerative repair. Mao L; Wang JQ Sheng Li Xue Bao; 2003 Jun; 55(3):233-44. PubMed ID: 12817287 [TBL] [Abstract][Full Text] [Related]
20. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]